Viatris (VTRS) Tax Provisions (2019 - 2026)
Viatris (VTRS) posted Tax Provisions of $54.8 million for Q2 2026, up 112.93% on a QoQ basis from -$423.7 million in Q1 2026, and up 125.79% year-over-year from $24.3 million in Q2 2025.
Analysis
Viatris (VTRS) Tax Provisions (2019 - 2026) Analysis & Trends
Viatris has reported Tax Provisions for 8 years, with the latest figure at $54.8 million in Q2 2026.
- On a quarterly basis, Tax Provisions rose 125.79% year-over-year to $54.8 million in Q2 2026; TTM through Jun 2026 was -$251.5 million, a 10.75% increase from a year earlier, with the FY2025 full-year figure at -$150.1 million, down 1464.55% from the prior year.
- Tax Provisions was $54.8 million for Q2 2026 at Viatris, up from -$423.7 million in the prior quarter.
- The five-year high for Tax Provisions was $457.7 million in Q4 2022, with the low at -$423.7 million in Q1 2026.
- Average Tax Provisions over 5 years is $20.8 million, with a median of $61.9 million recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Tax Provisions surged 2897.67% in 2025, then sank 670.36% in 2026.
- Over 5 years, Tax Provisions stood at $457.7 million in 2022, then tumbled by 119.53% to -$89.4 million in 2023, then surged by 88.81% to -$10.0 million in 2024, then jumped by 71.0% to -$2.9 million in 2025, then soared by 1989.66% to $54.8 million in 2026.
- The last three Tax Provisions figures came in at $54.8 million (Q2 2026), -$423.7 million (Q1 2026), and -$2.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | 121.00 Mn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 54.80 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 12.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 1.38 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 88.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -59,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 12.40 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 8.20 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | 42,000.00 |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.80 Mn |
| Mar 31, 2026 | -423.70 Mn |
| Dec 31, 2025 | -2.90 Mn |
| Sep 30, 2025 | 120.30 Mn |
| Jun 30, 2025 | -212.50 Mn |
| Mar 31, 2025 | -55.00 Mn |
| Dec 31, 2024 | -10.00 Mn |
| Sep 30, 2024 | -4.30 Mn |
| Jun 30, 2024 | -65.40 Mn |
| Mar 31, 2024 | 90.70 Mn |
| Dec 31, 2023 | -89.40 Mn |
| Sep 30, 2023 | 70.60 Mn |
| Jun 30, 2023 | 69.00 Mn |
| Mar 31, 2023 | 98.00 Mn |
| Dec 31, 2022 | 457.70 Mn |
| Sep 30, 2022 | 73.20 Mn |
| Jun 30, 2022 | 75.40 Mn |
| Mar 31, 2022 | 128.30 Mn |
| Dec 31, 2021 | 59.90 Mn |
| Sep 30, 2021 | -111.60 Mn |